Univest securities, llc announces successful closing of $5.1 million private placement for qualigen therapeutics, inc. (nasdaq: qlgn)

New york, nov. 25, 2024 (globe newswire) -- univest securities, llc (“univest”), a member of finra and sipc, and a full-service investment bank and securities broker-dealer firm based in new york, today announced the closing of private placement of 5,100 series a-2 preferred shares, with a stated value of us$1,000 per share, for its client qualigen therapeutics, inc. (nasdaq:qlgn) (“qualigen” or the “company”), a life science company focused on developing platform treatments for adult and pediatric cancers, with the potential for orphan drug designations.
QLGN Ratings Summary
QLGN Quant Ranking